Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype

EMBO Molecular Medicine(2022)10.15252/emmm.202012860Source: DataRank Database

CD38‐NADase is a new major contributor to Duchenne muscular dystrophic phenotype is a research paper published in EMBO Molecular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 2.66)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (25)

Abdallah Fayssoil ORCID,Mbarka Dakouane‐Giudicelli ORCID,Isley de Jesus,Ahmed Karoui ORCID,Faouzi Zarrouki ORCID

Live enrichment

PubMed:35298089 PMC:PMC9081905 OpenAlex:https://openalex.org/W4221096195

AFM‐telethon grants

Grant: 17036

Fondation de France

Grant: 00086505

Agence Nationale de la Recherche

Grant: NAD‐Heart # 17‐CE17‐0015‐01

Agence Nationale de la Recherche

Grant: ANR‐19‐CE14‐0031‐01

Agence Nationale de la Recherche

Grant: ANR‐13‐BSV1‐0023‐01

Foundation for the National Institutes of Health

Grant: AG58812

Agence Nationale de la Recherche

Grant: ANR‐10‐LABX‐33

NIA NIH HHS

Grant: R01 AG058812

FWCI

2.66

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202012860

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202012860

publisherhttps://link.springer.com/content/pdf/10.15252/emmm.202012860.pdf

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.15252/emmm.202012860

publisherhttps://link.springer.com/article/10.15252/emmm.202012860/fulltext.html

Fields of Study

Calcium signaling and nucleotide metabolismSirtuins and Resveratrol in MedicineSignaling Pathways in Disease

MeSH Terms

AnimalsHumansNADNAD+ NucleosidasePhenotypeMice, Inbred mdxMuscle, SkeletalMuscular Dystrophy, DuchenneMyocytes, CardiacMiceADP-ribosyl Cyclase 1

Keywords

Duchenne muscular dystrophyCD38mdx mouseRyanodine receptorNAD+ kinaseSkeletal muscleDystrophinMyogenesisMuscular dystrophyITGA7Internal medicineBiologyEndocrinologyChemistryMedicineCell biologyBiochemistryReceptorStem cellEnzymeCalciumDMDCardiomyopathyNad+

Sustainable Development Goals

SDG 0: Good health and well-being